Dobutamine vs Milrinone for Inferior STEMI with RVMI: A Retrospective Cohort Study

A retrospective cohort study of 211 patients with inferior ST-segment elevation myocardial infarction and suspected right ventricular involvement treated between June 2009 and June 2025. The data, authored by Si Wang, compares 30-day mortality and other outcomes between patients receiving dobutamine or milrinone.

Use Cases

• Compare 30-day mortality outcomes based on inotrope selection.
• Analyze duration of inotropic support based on patient hemodynamic phenotypes.
• Investigate associations between left ventricular dysfunction and treatment group assignment.

Strengths

• Data covers a 16-year period from June 2009 to June 2025.
• Study includes 211 patient records with 55 in the dobutamine group and 156 in the milrinone group.
• Analysis employed multiple statistical methods including multivariable Cox regression and inverse probability of treatment weighting.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• The study is from a single center, which may limit generalizability.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Single-center retrospective cohort study.

Time Range

June 2009 to June 2025

Freshness

Last updated 2026-05-15 05:42:53; freshness should be verified.